Your fact-checks will appear here
The use of feminizing hormones in transfeminine patients
Gender-affirming hormone therapy () commonly suppresses gametogenesis: estrogen plus anti-androgens reduces spermatogenesis in transfeminine people and testosterone suppresses ovulation in transmascul...
(FFS) reliably shifts external gender perception and patient-reported facial satisfaction: objective recognition as female rose from 54.5% pre-op to 93.7% post-op in one study, and median self-reporte...
Estrogen plus anti-androgens suppress sperm production by shutting down the hypothalamic–pituitary–gonadal axis within weeks, with many patients developing severe oligozoospermia or azoospermia by abo...